Decoy Therapeutics is trading at $0.91 (-6.69%), with the reason for its October 26 decline remaining unclear.

  • No company-specific announcement or catalyst explaining the decline surfaced in the available search.
  • Broader markets were higher, while biotech reporting was mixed; the biotech ETF was slightly higher, so the decline does not appear to track a sector selloff.
  • The supplied price history shows recent losses, but that prior weakness does not establish the cause.